Single-use bioreactors are disposable bioreactors used in the production of biopharmaceuticals. They help reduce risks of product cross-contamination as they are used only for a single process before being disposed. They also help reduce capital expenditure incurred on sterilization and validation of conventional stainless steel bioreactors. Single-use bioreactors have been growing in popularity as compared to conventional stainless-steel bioreactors owing to flexibility they offer along with faster setup times. The global Single-Use Bioreactor Market is estimated to be valued at US$ 1337.67 Mn in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The ability of single-use bioreactors to reduce capital expenditure for biopharmaceutical manufacturers represents a key market opportunity. Their disposable nature eliminates the need for costly sterilization and validation procedures required for conventional stainless steel bioreactors. This helps reduce capital tied up in fixed assets like piping, tanks etc. Their single-use design also avoids the need for complex and expensive clean-in-place and sterilization-in-place systems. With drug manufacturing moving towards decentralized and personalized production, adoption of single-use bioreactors is expected to rise as they offer enhanced flexibility of operation at a lower capital cost. This ability to optimize capital efficiency through their flexible and disposable nature is expected to drive further demand for single-use bioreactors over the forecast period.

Porter's Analysis

Threat of new entrants: The single-use bioreactor market has moderate threat of new entrants due to high capital requirements. However, new small manufacturers are entering the market gradually capturing niche applications.

Bargaining power of buyers: The bargaining power of buyers is moderate as there are few global players dominating the market. However, price sensitive large pharma companies can negotiate for discounts.

Bargaining power of suppliers: The bargaining power of suppliers is low due to availability of raw material suppliers. Hence established players can source materials at competitive prices.

Threat of new substitutes: Threat of new substitutes is low as single-use bioreactors are highly specialized with no close substitutes. However, some alternatives like steel tanks are used for low-value applications.

Competitive rivalry: The competitive rivalry is high among key global players focusing on new product innovation, capacity expansion and mergers.

SWOT Analysis
Strength: Flexible production, lower capital costs, ease of scale-up, lower risk of cross-contamination are key strengths.

Weakness: Limited reusability, high material costs, and lack of validation for some applications are weaknesses.

Opportunity: Rising demand for affordable biologics, cell therapies offers opportunities. Regional clusters in Asia Pacific and Middle East & Africa to boost access.

Threats: Trade barriers, stringent regulations can impact certain regional markets. technological advancements improve competitiveness of alternative technologies.

Key Takeaways

The global Single-Use Bioreactor Market Demand is expected to witness high growth due to rising demand for affordable biologics and cell therapies. North America region currently dominates the market due to presence of major players and significant research funding for cell-based therapies. Asia Pacific region is fastest growing market with China and India emerging as biotech clusters. Key players operating in the single-use bioreactor market are Sartorius AG, OmniBRx Biotechnologies, Merck KgaA, Solaris Biotechnology Srl, Eppendorf AG, Distek Inc., Celltainer Biotech BV, ABEC Inc., Thermo Fisher Scientific, and Danaher Corporation (Pall Corporation), among others.

Regional analysis related content comprises: Asia Pacific region is emerging as fastest growing market for single-use bioreactors. China, India, South Korea and Japan are major countries contributing to market growth. Wide acceptance of disposables in biopharma industry, intensive R&D to develop novel biologics and favorable regulatory environment are boosting adoption.

Key players related content comprises: Key players operating in the single-use bioreactor market are Sartorius AG, OmniBRx Biotechnologies, Merck KgaA, Solaris Biotechnology Srl, Eppendorf AG, Distek Inc., Celltainer Biotech BV, ABEC Inc., Thermo Fisher Scientific, and Danaher Corporation (Pall Corporation), among others. Sartorius AG is the global market leader with wide product portfolio and regional presence across major markets.

Get more insights on this topic: https://www.pressreleasebulletin.com/single-use-bioreactor-market-growth-demand-and-overview/